Abstract
Conventional HSK management is hindered by treatment-related complications. Integrating these biomarkers into clinical practice may help preserve corneal structure, and ultimately improve visual outcomes for patients with HSK.
Affiliated Institutions
Related Publications
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Abstract Triple-negative breast cancer (TNBC) remains the most challenging breast cancer subtype to treat. To date, therapies directed to specific molecular targets have rarely ...
Epidemiology and Management of Hepatocellular Carcinoma
The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice are becoming increasingly related to sustained virological response after hepatitis C...
Molecular therapies and precision medicine for hepatocellular carcinoma
The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass an annual incidence of 1 million cases. Genomic studies have established the land...
Gender-Related Differences in Acute Aortic Dissection
Background— Few data exist on gender-related differences in clinical presentation, diagnostic findings, management, and outcomes in acute aortic dissection (AAD). Methods and Re...
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices
Background— A treatment gap exists between heart failure (HF) guidelines and the clinical care of patients. The Registry to Improve the Use of Evidence-Based Heart Failure Thera...
Publication Info
- Year
- 2025
- Type
- article
- Pages
- 1-15
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1080/02713683.2025.2589345